Chikungunya IgG, 96 Wells

To add this product to your interest list, sign up or login.

Chikungunya IgG, 96 Wells

Manufacturer: DRG International Inc.
Model: Chikungunya IgG, 96 wells
Product Code: EIA5102

Buy Now

If you want to add the Chikungunya IgG, 96 wells to your laboratory or other establishment, you have come to the right place. We are Block Scientific, a well-known laboratory equipment supplier strategically situated in Bellport, New York and committed to matching the most suitable product to your requirement and delivering it promptly too.


IgG Elisa Kit

The Chikungunya IgG-ELISA is intended for the qualitative determination of IgG class antibodies to Chikungunya in human serum and plasma (citrate). It is a useful immunoenzymatic measurement of IgG-class antibodies to Chikungunya based on the ELISA (Enzyme-linked Immunosorbent Assay) technique.


  • Incubation: 60/30/30/30/15 min
  • Stand.Range/Sensitivity: neg., pos., cut-off control >90%
  • Specimen: 10 uL serum or plasma
  • Type: qualitative
  • Method: MTPL


Chikungunya virus is an arthropod borne virus of the genus Alphavirus (family Togaviridae). The Alphavirus genus contains at least 24 distinct species. These are lipid-enveloped virions with a diameter of 50 to 60 nm.

Alphavirus infections are initiated by the bite of an infected mosquito, which results in the deposition of virus in subcutaneous and possibly cutaneous tissues. After an incubation period of 1 to 12 days the Chikungunya fever develops. Chikungunya fever (Chikungunya means “that which bends up”, in reference to the crippling manifestations of the disease) is an acute viral infection characterized by a rapid transition from a state of good health to illness that includes severe arthralgia and fever. Temperature rises abruptly to as high as 40°C and is often accompanied by shaking chills. After a few days, fever may abate and recrudesce, giving rise to a “saddleback” fever curve. Arthralgia is polyarticular, favoring the small joints and sites of previous injuries, and is most intense on arising. Patients typically avoid movement as much as possible. Joints may swell without significant fluid accumulations. These symptoms may last from 1 week to several months and are accompanied by myalgia. The rash characteristically appears on the first day of illness, but onset may be delayed. It usually arises as a flush over the face and neck, which evolves to a maculopapular or macular form that may be pruritic. The latter lesions appear on the trunk, limbs, face, plams and soles, in that order of frequency. Petechial skin lesions have also been noted. Headache, photophobia, retro-orbitral pain, sore throat with objective signs of pharyngitis, nausea and vomiting also occur in this setting. Occasionally, however persistent arthralgia and polyarthritis (lasting months or even years) do occur, sometimes involving joint destruction. Even rarer, sequelae include encephalitis and meningoencephalitis with high lethality rates. The virus has major importance in Africa and Asia. From 20% to more than 90% of the population of tropical and subtropical show serologic evidence of infection. Because Aedes mosquitoes are increasingly prevalent in North Africa and South America, where the population would be uniformly susceptible to infection, the possibility for epidemics is evident. Chikungunya virus infections are imported to central Europe mainly by travellers to tropical and subtropical countries.

For convenient online purchase of the Chikungunya IgG, 96 wells and other infectious disease kits, visit our online store. If you have any queries pertaining to this product, dial 631-589-1118 or send an email to